|
Name: 4´-methyl-alpha-pyrrolidinohexiophenone (MPHP)
Type:
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP) is a synthetic stimulant that was first developed as part of research into new psychoactive substances. It belongs to a class of chemicals known as substituted cathinones, often referred to as 'bath salts.' MPHP was introduced to the market in the early 2010s, and its effects were similar to other stimulants, leading to its use in recreational settings. The substance quickly gained notoriety for its potent stimulant effects and potential for abuse. Regulatory agencies began to address its legality due to health risks associated with synthetic cathinones. The substance's rise and subsequent regulation reflect broader trends in the control of novel psychoactive substances.
|
|
V. Legal Information
4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP), a synthetic cathinone, is illegal in the US under Schedule I. Many countries have banned it due to its stimulant effects and health risks. The UNODC monitors synthetic cathinones, highlighting their potential for abuse. Trends show stricter regulations and penalties to address the growing concern of synthetic drug use.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP) is a synthetic stimulant similar to mephedrone. It increases heart rate and blood pressure. Short-term use may enhance alertness and mood, but long-term use can lead to cardiovascular issues, psychological problems, and dependency. Overdose risks include severe agitation, cardiovascular effects, and potential death. Safe use requires cautious dosing and monitoring. Recent research explores its stimulant effects and associated health risks.  |
|
VII. Psychological Effects
A stimulant with effects similar to other cathinones, causing euphoria and increased energy. Long-term use may lead to paranoia, aggression, and cognitive impairments. Research indicates its impact on neurotransmitter systems and associated psychological risks.
 |
|
VIII. Culture
4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) is a synthetic stimulant, classifying it as an upper. Short-term use increases energy, euphoria, and alertness, while long-term use can lead to cardiovascular issues and psychological dependence. Overdose risks include severe agitation, cardiovascular problems, and potential psychosis. Safe dosages are not well-established, with lower doses advised. Recent research emphasizes its stimulant effects and potential for abuse. Physical effects include dilated pupils, increased heart rate, and elevated blood pressure.
 |